You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Inflammatory bowel disease

Infliximab and adalimumab for the treatment of Crohn's disease

  • Technology appraisal guidance
  • Reference number: TA187
  • Published:  19 May 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Consultee and commentator comments on the ACD

  • Abbott

  • National Association for Colitis and Crohn's Disease

  • Royal College of Physicians & British Society of Gastroenterology

  • Schering Plough

  • Royal College of Nursing

  • Welsh Assembly Government (WAG)

  • Website responses

  • Department of Health


This page was last updated: 30 March 2010

Back to top